within Pharmacolibrary.Drugs.ATC.C;

model C07AA06
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.61,
    Cl             = 0.00038333333333333334,
    adminDuration  = 600,
    adminMass      = 20 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.06,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0095,
    Tlag           = 600,            
    Vdp             = 0.027,
    k12             = 57,
    k21             = 57
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C07AA06</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Timolol is a non-selective beta-adrenergic antagonist (beta-blocker) used primarily to treat hypertension, angina pectoris, and in ophthalmic form for increased intraocular pressure in glaucoma. It is approved for clinical use and available in systemic and ophthalmic formulations.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after a single oral dose.</p><h4>References</h4><ol><li><p>Fourtillan, JB, Courtois, P, Lefebvre, MA, &amp; Girault, J (1981). Pharmacokinetics of oral timolol studied by mass fragmentography. <i>European journal of clinical pharmacology</i> 19(3) 193–196. DOI:<a href=\"https://doi.org/10.1007/BF00561948\">10.1007/BF00561948</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7215417/\">https://pubmed.ncbi.nlm.nih.gov/7215417</a></p></li><li><p>Wilson, TW, Firor, WB, Johnson, GE, Holmes, GI, Tsianco, MC, Huber, PB, &amp; Davies, RO (1982). Timolol and propranolol: bioavailability, plasma concentrations, and beta blockade. <i>Clinical pharmacology and therapeutics</i> 32(6) 676–685. DOI:<a href=\"https://doi.org/10.1038/clpt.1982.223\">10.1038/clpt.1982.223</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7140133/\">https://pubmed.ncbi.nlm.nih.gov/7140133</a></p></li><li><p>Else, OF, Sorenson, H, &amp; Edwards, IR (1978). Plasma timolol levels after oral and intravenous administration. <i>European journal of clinical pharmacology</i> 14(6) 431–434. DOI:<a href=\"https://doi.org/10.1007/BF00716385\">10.1007/BF00716385</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/738350/\">https://pubmed.ncbi.nlm.nih.gov/738350</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C07AA06;
